Delivery Order SPE2DR25D3404-SPE2DR26F5V9S
Award Date 1/22/26
Potential Completion Date 2/12/26
Potential Value $90K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $126,664.80 on December 15, 2025, for the supply of Ocrevus 300 mg/10 ml vials. This non-competitive, firm fixed-price delivery order is scheduled for completion by January 7, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government, specifically...
- The Defense Logistics Agency awarded a delivery order valued at $25,332.96 to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 ml vials on December 30, 2025. This firm fixed-price delivery order, with an ultimate completion date of January 22, 2026, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was competitively procured with no set-aside designation and will be performed at the vendor's...
- The Defense Logistics Agency (DLA) awarded a $75,998.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 mL vials. The contract was competitively awarded without set-aside provisions and is scheduled for completion by November 19, 2025. AmerisourceBergen will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- Amerisourcebergen Drug Corp, a pharmaceutical distribution company, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical valued at $23,118.08. The order is for the supply of OCREVUS 300 MG/10 ML VIAL 10ML, a specialty pharmaceutical product, with a completion date of February 26, 2024. Amerisourcebergen Drug Corp has previously received numerous federal contract awards from DLA to provide a range of pharmaceutical and medical supplies in...
- The Defense Logistics Agency awarded a $51,275.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 20, 2026, for the supply of Ocrevus 300 mg/10 mL vials. This is a non-set-aside award with an ultimate completion date of February 10, 2026, and performance will occur at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Ocrevus 300 mg/10 mL vials valued at $32,694.46 under a firm fixed-price contract. The delivery order is non-set-aside and competitively awarded, with a completion date of June 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $116,362.50 on November 10, 2025, for the supply of Ocrevus 300 mg/10 mL vials. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of December 3, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $22,618.72 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide Ocrevus 300 MG/10 ML vials. Performance will take place in Conshohocken, Pennsylvania over a period of approximately one month, from September 29th through October 23rd, 2023. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring pharmaceuticals...
- The Defense Logistics Agency awarded a delivery order valued at $51,275.40 to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 mL vials on January 22, 2026, with an ultimate completion date of February 12, 2026. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded transaction within the federal pharmaceutical procurement process. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation. This $23,118.08 contract is for the supply of OCREVUS 300 mg/10 ml vials, a specialty medication, to support military treatment programs and facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical valued up to...